Walmart, Inc | Report on Impacts of Reproductive Healthcare Legislation at Walmart, Inc

Status
12.92% votes in favour
AGM date
Resolution details
Company ticker
WMT
Resolution ask
Report on or disclose
ESG theme
  • Social
ESG sub-theme
  • Other social issues
Company sector
Consumer Discretionary
Company HQ country
United States
Resolved clause
Shareholders request that Walmart Board of Directors issue a public report prior to December 31, 2022, omitting confidential and privileged information and at a reasonable expense, detailing any known and any potential risks and costs to the Company caused by enacted or proposed state policies severely restricting reproductive rights, and detailing any strategies beyond litigation and legal compliance that the Company may deploy to minimize or mitigate these risks.
Supporting statement
Shareholders recommend that the report evaluate any risks and costs to the company associated with new laws and legislation severely restricting reproductive rights, and similar restrictive laws proposed or enacted in other states. In its discretion, the board’s analysis may include any effects on employee hiring, retention, and productivity, and decisions regarding closure or expansion of operations in states proposing or enacting restrictive laws and strategies such as any public policy advocacy by the company, related political contributions policies, and human resources or educational strategies.